GlassScriptPhysician profile
Marc D Hirsch
NPI 1386624120
$3,359.05
in general payments reported to CMS, 2019-2025
25 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $55.43 · 2021: $71.41 · 2022: $512 · 2023: $422 · 2024: $1,159 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,265 · Education: $40.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,265.06 |
| Education | $40.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $673.00 | 2022-2025 | Eylea Hd |
| Alcon Vision LLC | $606.97 | 2019-2025 | Clareon, Rocklatan |
| Glaukos Corporation | $455.46 | 2022-2025 | Ce-Marked Kxla System, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Apellis Pharmaceuticals, INC. | $316.90 | 2023-2025 | Syfovre |
| New World Medical,INC. | $271.36 | 2019-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Tarsus Pharmaceuticals, INC. | $185.48 | 2024-2025 | Xdemvy |
| The Cameron-Ehlen Group, INC. | $109.57 | 2019-2022 | |
| Ocular Therapeutix, INC. | $88.18 | 2022-2023 | Dextenza |
| Abbvie INC. | $83.85 | 2023 | |
| Harrow Eye, LLC | $74.61 | 2024 | Vevye, Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.65 | 2019 | |
| Dompe US, INC. | $59.25 | 2022-2025 | Oxervate |
| Omeros Corporation | $51.32 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $50.13 | 2022-2024 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Sandoz INC. | $37.76 | 2025 | Cimerli |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $37.02 | 2019-2020 | |
| Thea Pharma INC. | $33.41 | 2023-2024 | Iyuzeh |
| Astellas Pharma US INC | $31.48 | 2024 | Izervay |
| Biotissue Holdings INC. | $22.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $19.96 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.95 | 2025 | Zilretta, Iovera |
| Rxsight INC | $19.93 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $16.82 | 2024 | Miebo, Xiidra |
| Sight Sciences, INC. | $16.04 | 2021 | |
| Quidel Corporation | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.